A Scaffold-Aware Machine Learning Docking Pipeline for TYK2 Inhibitor Discovery with Calibrated Prioritization of 32 Active Compounds Including Deucravacitinib. IRJMSS [Internet]. 2025 Dec. 31 [cited 2026 Feb. 12];6(4):42-55. Available from: https://irjmss.com/index.php/irjmss/article/view/484